I agree that this site is using cookies. You can find further informations here.
X
Madu, Max F.
48  results:
Search for persons X
?
1

Author Correction: Reversal of pre-existing NGFR-driven tum..:

Boshuizen, Julia ; Vredevoogd, David W. ; Krijgsman, Oscar...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
2

Reversal of pre-existing NGFR-driven tumor and immune thera..:

Boshuizen, Julia ; Vredevoogd, David W. ; Krijgsman, Oscar...
Nature Communications.  11 (2020)  1 - p. , 2020
Link: https://doi.org/10.1038/..
 
?
3

Challenges in sentinel node pathology in the era of adjuvan..:

Franke, Viola ; Madu, Max F. ; Bierman, Carolien...
Journal of Surgical Oncology.  , 2020
Link: https://doi.org/10.1002/..
 
?
4

Parotidectomy in patients with head and neck cutaneous mela..:

Berger, Danique M.S. ; van Veen, Martinus M. ; Madu, Max F....
Head & Neck.  41 (2019)  7 - p. 2264-2270 , 2019
Link: https://doi.org/10.1002/..
 
?
5

Reply to: Letter re: Efficacy of isolated limb perfusion (I..:

van Veenendaal, Linde M. ; Madu, Max F. ; Tesselaar, Margot E.T....
European Journal of Surgical Oncology.  45 (2019)  6 - p. 1122-1123 , 2019
Link: https://doi.org/10.1016/..
 
?
6

Immediate completion lymph node dissection in stage IIIA me..:

Madu, Max F. ; Franke, Viola ; Bruin, Maarten M....
European Journal of Cancer.  87 (2017)  - p. 212-215 , 2017
Link: https://doi.org/10.1016/..
 
?
7

Clinical prognostic markers in stage IIIC melanoma:

Madu, Max F. ; Schopman, Jaap H.H. ; Berger, Danique M.S....
Journal of Surgical Oncology.  116 (2017)  2 - p. 244-251 , 2017
Link: https://doi.org/10.1002/..
 
?
8

Concurrent Merkel Cell Carcinoma and Melanoma in Individual..:

Madu, Max F. ; van Veenendaal, Linde M. ; van de Wiel, Bart..
Clinical Skin Cancer.  2 (2017)  1-2 - p. 69-72 , 2017
Link: https://doi.org/10.1016/..
 
?
9

Isolated Limb Perfusion for Melanoma is Safe and Effective ..:

Madu, Max F. ; Deken, Marion M. ; van der Hage, Jos A....
Annals of Surgical Oncology.  24 (2017)  7 - p. 1997-2005 , 2017
Link: https://doi.org/10.1245/..
 
?
10

Neoadjuvant Cytoreductive Treatment of Regionally Advanced ..:

Madu, Max F. ; Rozeman, E.A. Lisette ; van der Hage, Jos A....
Clinical Skin Cancer.  1 (2016)  1 - p. 48-52 , 2016
Link: https://doi.org/10.1016/..
 
?
11

Clinical Prognostic Markers in Stage IIIB Melanoma:

Madu, Max F. ; Wouters, Michel W. J. M. ; Klop, W. Martin C....
Annals of Surgical Oncology.  23 (2016)  13 - p. 4195-4202 , 2016
Link: https://doi.org/10.1245/..
 
?
12

Author Correction: Reversal of pre-existing NGFR-driven tum..:

Boshuizen, Julia ; Vredevoogd, David W ; Krijgsman, Oscar...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905532/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
13

Reversal of pre-existing NGFR-driven tumor and immune thera..:

Boshuizen, Julia ; Vredevoogd, David W ; Krijgsman, Oscar...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414147/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
14

Author Correction: Reversal of pre-existing NGFR-driven tum..:

Julia Boshuizen ; David W. Vredevoogd ; Oscar Krijgsman...
https://doi.org/10.1038/s41467-023-35852-2.  , 2023
Link: https://doi.org/10.1038/..
 
?
15

Reversal of pre-existing NGFR-driven tumor and immune thera..:

Julia Boshuizen ; David W. Vredevoogd ; Oscar Krijgsman...
https://doi.org/10.1038/s41467-020-17739-8.  , 2020
Link: https://doi.org/10.1038/..
 
1-15